Modulation of humoral immune responses and inhibition of proinflammatory cytokines and nitric oxide production by 10-methoxycanthin-6-one

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 1, 2012, Pages 116-125

  Siveen, K S ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

10 Methoxycanthin 6 one; Antibody titer; Nitric oxide; Plaque forming cells in spleen; Proinflammatory cytokines

Indexed keywords

10 METHOXYCANTHIN 6 ONE; ANTIBODY; BETA CARBOLINE DERIVATIVE; CYCLOOXYGENASE 2; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AERVA LANATA; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; HUMORAL IMMUNITY; IMMUNOMODULATION; LEUKOCYTE COUNT; MACROPHAGE; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; TOXICITY TESTING;

AMARANTHACEAE; ANIMALS; CARBOLINES; CYTOKINES; IMMUNITY, HUMORAL; IMMUNOLOGIC FACTORS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SHEEP;

EID: 84055199397     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2011.586703     Document Type: Article

References (35)

1. Gokhale, A.B., Damre, A.S., Saraf, M.N. Investigations into the immunomodulatory activity of Argyreia speciosa. J Ethnopharmacol 2003, 84, 109-114. (Pubitemid 36034243)
2. Boscá, L., Zeini, M., Través, P.G., Hortelano, S. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology 2005, 208, 249-258. (Pubitemid 40187335)
3. Schimmer, B.P., Parker, K.L. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman, J.G., Limbird, L.E., Goodman, G.A., editors. The Pharmacological Basis of Therapeutics, 10th edition. New York: McGraw-Hill, 2001, pp. 1649-1677.
4. Jung, H.W., Seo, U.K., Kim, J.H., Leem, K.H., Park, Y.K. Flower extract of Panax notoginseng attenuates lipopolysaccharideinduced inflammatory response via blocking of NF-kappaB signaling pathway in murine macrophages. J Ethnopharmacol 2009, 122, 313-319.
5. Cragg, G.M., Newman, D.J. Antineoplastic agents from natural sources: achievements and future directions. Expert Opin Investig Drugs 2000, 9, 2783-2797.
6. Ammirante, M., Di Giacomo, R., De Martino, L., Rosati, A., Festa, M., Gentilella, A., Pascale, M.C., Belisario, M.A., Leone, A., Turco, M.C., De Feo, V. 1-Methoxy-canthin-6-one induces c-Jun NH2- terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin. Cancer Res 2006, 66, 4385-4393.
7. Siveen, K.S., Kuttan, G. Immunomodulatory and antitumor activity of Aerva lanata ethanolic extract. Immunopharmacol Immunotoxicol 2010.
8. Zapesochnaya, G., Kurkin, V., Okhanov, V., Miroshnikov, A. Canthin-6-one and beta-carboline alkaloids from Aerva lanata. Planta Med 1992, 58, 192-196.
9. King, J. The phosphatases. In: Van Nostrand, D., editor. Practical Clinical Enzymology. London: Nostrand Company Limited, 1965, pp. 91-208.
10. Bergmeyer, H., Bernt, E. Colorimetric method for aspartate aniline aminotransferases. In: Varley, H., Gowenlock, A., Bell, M., editors. Practical Clinical Biochemistry, 5th edition. London: William Heine-mann Medical Books Ltd., 1980, pp. 741-742.
11. Toro, G., Ackermann, P. Practical Clinical Chemistry. Boston: Little Brown & Co., 1975, p. 154.
12. Murray, R. Nonprotein compounds. In: Kaplan, L., Pesce, A., editors. Clinical Chemistry: Theory, Analysis and Co-relation. Toranto: Mosby C.V., 1984, pp. 1230-1268.
13. Sredni, B., Albeck, M., Kazimirsky, G., Shalit, F. The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent. Int J Immunopharmacol 1992, 14, 613-619.
14. Bancroft, J.D., Cook, H.C. Manual of Histological Techniques. London: Churchill Livingstone, 1984, p. 274.
15. Manu, K.A., Kuttan, G. Immunomodulatory activities of punarnavine, an alkaloid from Boerhaavia diffusa. Immunopharmacol Immunotoxicol 2009, 31, 377-387.
16. Hamsa, T.P., Kuttan, G. Ipomoea obscura (L.) enhances the functions of immunological effector cells, inhibits proinflammatory cytokines and nitric oxide production by LPS induced macrophages. Immunopharmacol Immunotoxicol 2009, 31, 222-229.
17. Jerne, N.K., Nordin, A.A. Plaque formation in agar by single antibody-producing cells. Science 1963, 140, 405.
18. Stuehr, D.J., Nathan, C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989, 169, 1543-1555. (Pubitemid 19126814)
19. Alexeeff, G.V., Broadwin, R., Liaw, J., Dawson, S.V. Characterization of the LOAEL-to-NOAEL uncertainty factor for mild adverse effects from acute inhalation exposures. Regul Toxicol Pharmacol 2002, 36, 96-105. (Pubitemid 36160148)
20. Pratheeshkumar, P., Kuttan, G. Modulation of immune response by Vernonia cinerea L. inhibits the proinflammatory cytokine profile, iNOS, and COX-2 expression in LPS-stimulated macrophages. Immunopharmacol Immunotoxicol 2010, 1-11.
21. Guruvayoorappan, C., Kuttan, G. Immunomodulatory and antitumor activity of Biophytum sensitivum extract. Asian Pac J Cancer Prev 2007, 8, 27-32.
22. Davis, L., Kuttan, G. Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 2000, 71, 193-200. (Pubitemid 30440669)
23. Mathew, S., Kuttan, G. Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J Exp Clin Cancer Res 1997, 16, 407-411. (Pubitemid 28083542)
24. Sunila, E.S., Kuttan, G. Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J Ethnopharmacol 2004, 90, 339-346. (Pubitemid 38180485)
25. Raphael, T.J., Kuttan, G. Immunomodulatory activity of naturally occurring monoterpenes carvone, limonene, and perillic acid. Immunopharmacol Immunotoxicol 2003, 25, 285-294. (Pubitemid 36597423)
26. Thejass, P., Kuttan, G. Immunomodulatory activity of sulforaphane, a naturally occurring isothiocyanate from broccoli (Brassica oleracea). Phytomedicine 2007, 14, 538-545. (Pubitemid 47068945)
27. Manesh, C., Kuttan, G. Effect of naturally occurring isothiocyanates on the immune system. Immunopharmacol Immunotoxicol 2003, 25, 451-459. (Pubitemid 37204454)
28. Andreakos, E., Foxwell, B., Feldmann, M. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol Rev 2004, 202, 250-265. (Pubitemid 39576917)
29. Bondeson, J. The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen Pharmacol 1997, 29, 127-150. (Pubitemid 27312362)
30. Dinarello, C.A. Biology of interleukin 1. FASEB J 1988, 2, 108-115.
31. Hirano, T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 1992, 62, S60-S65.
32. Moncada, S. Nitric oxide: discovery and impact on clinical medicine. J R Soc Med 1999, 92, 164-169. (Pubitemid 29213859)
33. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992, 6, 3051-3064.
34. Rocca, B., FitzGerald, G.A. Cyclooxygenases and prostaglandins: shaping up the immune response. Int Immunopharmacol 2002, 2, 603-630. (Pubitemid 34246363)
35. Turini, M.E., DuBois, R.N. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002, 53, 35-57. (Pubitemid 34177870)